Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
145M
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
38.8M
-
Shares change
-
+748K
-
Total reported value, excl. options
-
$446M
-
Value change
-
+$6.73M
-
Number of buys
-
55
-
Number of sells
-
-31
-
Price
-
$11.49
Significant Holders of Annexon, Inc. - Common Stock, par value $0.001 (ANNX) as of Q4 2021
104 filings reported holding ANNX - Annexon, Inc. - Common Stock, par value $0.001 as of Q4 2021.
Annexon, Inc. - Common Stock, par value $0.001 (ANNX) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.8M shares
of 145M outstanding shares and own 26.72% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (3.24M shares), Redmile Group, LLC (3.23M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.88M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.85M shares), BlackRock Inc. (2.61M shares), PICTET ASSET MANAGEMENT SA (2.16M shares), ALLIANCEBERNSTEIN L.P. (2.09M shares), FEDERATED HERMES, INC. (2.03M shares), SATTER MANAGEMENT CO., L.P. (1.95M shares), and CITADEL ADVISORS LLC (1.48M shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.